Mirae Asset Global ETFs Holdings’s Pliant Therapeutics PLRX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-33,923	Closed	-$45.8K	–	3180
2025 Q1	$45.8K	Buy	33,923 +1,492	+5%	+$9.06K	﹤0.01%	2865
2024 Q4	$427K	Buy	32,431 +1,141	+4%	+$15.6K	﹤0.01%	1999
2024 Q3	$351K	Buy	31,290 +2,004	+7%	+$25.1K	﹤0.01%	2091
2024 Q2	$315K	Buy	+29,286	New	+$378K	﹤0.01%	2044

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's PLRX Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Pliant Therapeutics (PLRX) in Q2 2025, closing a stake of 33,923 shares — an estimated $45.8K sold.

Mirae Asset Global ETFs Holdings first reported a position in PLRX in Q2 2024 and held it in 4 quarters. The position peaked at $427K in Q4 2024. 114 funds tracked by Wall St. Rank hold PLRX as of Q2 2025.

Mirae Asset Global ETFs Holdings reported no remaining Pliant Therapeutics position as of Q2 2025 after selling out during the quarter.
Mirae Asset Global ETFs Holdings sold 33,923 Pliant Therapeutics shares in Q2 2025, an estimated $45.8K.
Mirae Asset Global ETFs Holdings first reported a position in Pliant Therapeutics in Q2 2024 and held it in 4 quarters.
Mirae Asset Global ETFs Holdings's Pliant Therapeutics position peaked at $427K in Q4 2024.
114 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.